DEVELOPMENT OF ISLET-TARGETED DRUG DELIVERY STRATEGIES IN T1D

JUVENILE DIABETES RESEARCH FOUNDATION (JDRF)

Object

Topic: Diabetes.

Destination: JDRF aims to catalyze and support innovative studies for the selective delivery of therapeutics (bioactive molecules) to human beta cells, or other major pancreatic cell types, to promote survival and restore functional beta-cell mass in type 1 diabetes (T1D).

Budget: $900,000.

Duration: 3 years.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: